Identification and validation of anoikis-related lncRNAs for prognostic significance and immune microenvironment characterization in ovarian cancer

被引:0
作者
Cao, Lixue [1 ]
Zhang, Shaofen [2 ]
Peng, Haojie [3 ]
Lin, Yongqing [4 ]
Xi, Zhihui [1 ]
Lin, Wumei [4 ]
Guo, Jialing [1 ]
Wu, Geyan [5 ]
Yu, Fei [1 ]
Zhang, Hui [6 ]
Ye, Haiyan [2 ]
机构
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Med Res Inst, Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 2, Dept Breast Surg, Guangzhou, Guangdong, Peoples R China
[4] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Gynecol, Guangzhou, Guangdong, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 3, Biomed Res Ctr, Guangzhou, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immun, Zhongshan Sch Med, Minist Educ,Inst Human Virol,Key Lab Trop Dis Cont, Guangzhou, Guangdong, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 02期
关键词
anoikis; risk model; lncRNA; immune microenvironment; ovarian cancer; LONG NONCODING RNA; RESISTANCE; OBSTRUCTION; ASCITES; GROWTH; CELLS;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Anoikis, a form of apoptotic cell death resulting from inadequate cell-matrix interactions, has been implicated in tumor progression by regulating tumor angiogenesis and metastasis. However, the potential roles of anoikisrelated long non-coding RNAs (arlncRNAs) in the tumor microenvironment are not well understood. In this study, five candidate lncRNAs were screened through least absolute shrinkage and selection operator (LASSO), and multivariate Cox regression analysis based on differentially expressed lncRNAs associated with anoikisrelated genes (ARGs) from TCGA and GSE40595 datasets. The prognostic accuracy of the risk model was evaluated using Kaplan-Meier survival analysis and receiver operating characteristic (ROC) curves. Furthermore, Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene set enrichment analysis (GSEA) analyses revealed significant differences in immune-related hallmarks and signal transduction pathways between the high-risk and low-risk groups. Additionally, immune infiltrate analysis showed significant differences in the distribution of macrophages M2, follicular T helper cells, plasma cells, and neutrophils between the two risk groups. Lastly, silencing the expression of PRR34_AS1 and SPAG5_AS1 significantly increased anoikis-induced cell death in ovarian cancer cells. In conclusion, our study constructed a risk model that can predict clinicopathological features, tumor microenvironment characteristics, and prognosis of ovarian cancer patients. The immunerelated pathways identified in this study may offer new treatment strategies for ovarian cancer.
引用
收藏
页码:1463 / 1483
页数:21
相关论文
共 53 条
[1]   Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming [J].
Adeshakin, Funmilayo O. ;
Adeshakin, Adeleye O. ;
Afolabi, Lukman O. ;
Yan, Dehong ;
Zhang, Guizhong ;
Wan, Xiaochun .
FRONTIERS IN ONCOLOGY, 2021, 11
[2]   Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity [J].
Alspach, Elise ;
Lussier, Danielle M. ;
Schreiber, Robert D. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2019, 11 (03)
[3]   Oxidative Phosphorylation as an Emerging Target in Cancer Therapy [J].
Ashton, Thomas M. ;
McKenna, W. Gillies ;
Kunz-Schughart, Leoni A. ;
Higgins, Geoff S. .
CLINICAL CANCER RESEARCH, 2018, 24 (11) :2482-2490
[4]   Long Noncoding RNA and Cancer: A New Paradigm [J].
Bhan, Arunoday ;
Soleimani, Milad ;
Mandal, Subhrangsu S. .
CANCER RESEARCH, 2017, 77 (15) :3965-3981
[5]   Extracellular Glutathione Peroxidase GPx3 and Its Role in Cancer [J].
Chang, Caroline ;
Worley, Beth L. ;
Phaeton, Rebecca ;
Hempel, Nadine .
CANCERS, 2020, 12 (08) :1-20
[6]   Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells [J].
Dolinschek, Romana ;
Hingerl, Julia ;
Benge, Anke ;
Zafiu, Christian ;
Schuren, Elisabeth ;
Ehmoser, Eva-Kathrin ;
Lossner, Daniela ;
Reuning, Ute .
MOLECULAR ONCOLOGY, 2021, 15 (02) :503-522
[7]   Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis [J].
Elgendy, Mohamed ;
Ciro, Marco ;
Hosseini, Amir ;
Weiszmann, Jakob ;
Mazzarella, Luca ;
Ferrari, Elisa ;
Cazzoli, Riccardo ;
Curigliano, Giuseppe ;
DeCensi, Andrea ;
Bonanni, Bernardo ;
Budillon, Alfredo ;
Pelicci, Pier Giuseppe ;
Janssens, Veerle ;
Ogris, Manfred ;
Baccarini, Manuela ;
Lanfrancone, Luisa ;
Weckwerth, Wolfram ;
Foiani, Marco ;
Minucci, Saverio .
CANCER CELL, 2019, 35 (05) :798-+
[8]   Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer [J].
Emmons, Tiffany R. ;
Giridharan, Thejaswini ;
Singel, Kelly L. ;
Khan, Anm Nazmul H. ;
Ricciuti, Jason ;
Howard, Kaitlyn ;
Silva-Del Toro, Stephanie L. ;
Debreceni, Ivy L. ;
Aarts, Cathelijn E. M. ;
Brouwer, Mieke C. ;
Suzuki, Sora ;
Kuijpers, Taco W. ;
Jongerius, Ilse ;
Allen, Lee-Ann H. ;
Ferreira, Viviana P. ;
Schubart, Anna ;
Sellner, Holger ;
Eder, Jorg ;
Holland, Steven M. ;
Ram, Sanjay ;
Lederer, James A. ;
Eng, Kevin H. ;
Moysich, Kirsten B. ;
Odunsi, Kunle ;
Yaffe, Michael B. ;
Zsiros, Emese ;
Segal, Brahm H. .
CANCER IMMUNOLOGY RESEARCH, 2021, 9 (07) :790-810
[9]   Single tumor-initiating cells evade immune clearance by recruiting type II macrophages [J].
Guo, Xiaocan ;
Zhao, Yang ;
Yan, Huan ;
Yang, Yingcheng ;
Shen, Shuying ;
Dai, Xiaoming ;
Ji, Xinyan ;
Ji, Fubo ;
Gong, Xing-Guo ;
Li, Li ;
Bai, Xueli ;
Feng, Xin-Hua ;
Liang, Tingbo ;
Ji, Junfang ;
Chen, Lei ;
Wang, Hongyang ;
Zhao, Bin .
GENES & DEVELOPMENT, 2017, 31 (03) :247-259
[10]   LncRNA SAMMSON Mediates Adaptive Resistance to RAF Inhibition in BRAF-Mutant Melanoma Cells [J].
Han, Shujun ;
Yan, Yuwei ;
Ren, Yibo ;
Hu, Yiming ;
Wang, Yan ;
Chen, Lei ;
Zhi, Zhe ;
Zheng, Yan ;
Shao, Yongping ;
Liu, Jiankang .
CANCER RESEARCH, 2021, 81 (11) :2918-2929